NDC codes

FDA NDC Directory
Product NDC (as listed)68001-155Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68001-0155Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68001-155-04680010155046800101550430 TABLET, COATED in 1 BOTTLE (68001-155-04)Marketed from Jan 1, 2014
68001-155-0868001015508680010155081000 TABLET, COATED in 1 BOTTLE (68001-155-08)Marketed from Jan 1, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Anastrozole
Generic name (nonproprietary)
anastrozole
Active ingredients
Anastrozole — 1 mg/1
Dosage form
Tablet, Coated
Route
Oral
Labeler
BluePoint LaboratoriesNDC labeler code 68001
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 078921
Marketing start
Listing expires
Other FDA classes
Aromatase Inhibitors (Mechanism)
Identifiers
Product ID 68001-155_2dc9d4ae-4fbc-df45-e063-6394a90a09a0SPL ID 2dc9d4ae-4fbc-df45-e063-6394a90a09a0SPL set ID 3cd04ed6-7c5a-4c4a-9955-ee40839dfea0RxCUI 199224UNII 2Z07MYW1AZUPC 0368001155045
Pharmacologic class
Aromatase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468001015504 followed by a unit qualifier and the quantity

Package 68001-0155-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Anastrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole ( 1.3 ) 1.1 Adjuvant Treatment Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hor…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68001-155

What is NDC 68001-155?
68001-155 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, coated, listed with the FDA by BluePoint Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Anastrozole.
What is the active ingredient?
Anastrozole.
Who is the labeler?
BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anastrozole?
38 other product NDCs are listed under this name. See all Anastrozole NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anastrozole NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
AnastrozoleAnastrozole 1 mg/1TabletOralDirect_Rx72189-68272189-0682-30
AnastrozoleAnastrozole 1 mg/1Tablet, Film coatedOralPD-Rx Pharmaceuticals, Inc.72789-57572789-0575-1572789-0575-30
Anastrozoleanastrozole tabletsAnastrozole 1 mg/1TabletOralUpsher-Smith Laboratories, LLC24979-72524979-0725-0624979-0725-07
AnastrozoleAnastrozole 1 mg/1TabletOralAvKARE42291-01642291-0016-3042291-0016-90
AnastrozoleAnastrozole 1 mg/1TabletOralDirect_Rx72189-41572189-0415-30
AnastrozoleAnastrozole 1 mg/1Tablet, Film coatedOralAurobindo Pharma Limited59651-23659651-0236-3059651-0236-90
AnastrozoleAnastrozole 1 mg/1Tablet, Film coatedOralAvKARE42291-08542291-0085-3042291-0085-90
AnastrozoleAnastrozole 1 mg/1TabletOralAvPAK50268-07550268-0075-15
Anastrozoleanastrozole tabletsAnastrozole 1 mg/1TabletOralAvet Pharmaceuticals Inc23155-85723155-0857-0323155-0857-0523155-0857-09
AnastrozoleAnastrozole 1 mg/1TabletOralChartwell RX, LLC62135-49062135-0490-3062135-0490-90

All 39 Anastrozole NDCs

Other NDCs under ANDA 078921

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078921
ProductStrengthForm · routeLabelerProduct NDC
AnastrozoleAnastrozole 1 mg/1Tablet, CoatedOralAmerican Health Packaging60687-112
AnastrozoleAnastrozole 1 mg/1Tablet, CoatedOralZydus Lifesciences Limited65841-743
AnastrozoleAnastrozole 1 mg/1Tablet, CoatedOralZydus Pharmaceuticals USA Inc.68382-209
AnastrozoleAnastrozole 1 mg/1Tablet, CoatedOralBryant Ranch Prepack71335-3145
AnastrozoleAnastrozole 1 mg/1Tablet, CoatedOralPD-Rx Pharmaceuticals, Inc.72789-342

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in